Tag Archives: Abbott Labs v. Sandoz

ABBOTT LABS. v. SANDOZ, INC. – ONE RULE FITS ALL?

Or “what’s sauce for the goose is sauce for the gander”? Posts and pens have been busy reporting that the Federal Circuit, en banc, overruled Scripps v. Genentech, and ended the debate over whether a product-by-process claims should be construed … Continue reading

Posted in Claim Interpretation | Tagged , , , , , , | Leave a comment